Home> Products> overactive bladder treatment frequency

{ "products": [ { "_id": "6667de6e00e7d2232cab2b6f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SOLIFENAC 5 ", "description": "SOLIFENAC 5 \nSolifenacin (5mg)\nSolifenacin 5mg is a medication used to treat overactive bladder symptoms such as urinary frequency, urgency, and incontinence. It belongs to the anticholinergic class of drugs, which work by relaxing the bladder muscles to improve control over urination.\n\nUsage: Take Solifenacin 5mg orally once daily, preferably at the same time each day.\nEffectiveness: It helps reduce urinary frequency and urgency, improving bladder control.\nSide Effects: Common side effects may include dry mouth, constipation, blurred vision, and dizziness.\nPrecautions: Inform your doctor about any medical conditions or medications you are taking before using Solifenacin.\nPrice: Prices vary depending on the brand and pharmacy. Check with your local pharmacy for accurate pricing.\nConclusion: Solifenacin 5mg is an effective treatment for overactive bladder symptoms, but it may cause side effects. Consult your doctor for proper guidance and dosage adjustments if needed. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \nhttps://www.sterisonline.com/product/solifenac-5-133510", "price": 421.0, "discountamount": 127.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Price", "Usage", "Order", "brand", "drugs", "Email", "doctor", "urgency", "WhatsApp", "same time", "dry mouth", "dizziness", "urination", "Conclusion", "medication", "Precautions", "information", "sterispharma", "constipation", "sterisonline", "incontinence", "Effectiveness", "local pharmacy", "blurred vision", "Solifenacin 5mg", "proper guidance", "bladder control", "bladder muscles", "accurate pricing", "urinary frequency", "dosage adjustments", "medical conditions", "effective treatment", "Common side effects", "anticholinergic class", "overactive bladder symptoms" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1697, "imageuri": "https://productimages.withfloats.com/actual/667d38c3ce74849f89ce0458.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d38c3ce74849f89ce0458.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-11T05:19:42.631Z", "updatedon": "2026-03-17T06:10:05.159Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/solifenac-5-/1697", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SOLIFENAC 5 ", "category": "UROLOGYRANGE", "tags": [ "SOLIFENAC 5", "Solifenacin 5mg dosage", "Solifenacin 5mg", "solifenacin 5mg tablets", "Solifenacin 5mg pil", "Solifenacin 5mg price", "Solifenacin 5mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6666d38433ebd40c046c974f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MIRAGRON ER 50", "description": "MIRAGRON ER 50\nMirabegron (50mg)\nMirabegron ER 50 (Mirabegron 50mg) is a medication used to treat overactive bladder (OAB) symptoms like frequent urination, urgency, and incontinence. It belongs to a class of drugs called beta-3 adrenergic agonists, which work by relaxing the bladder muscles, reducing urinary frequency and urgency.\n\nDrug Class: Beta-3 Adrenergic Agonist\nIndications: Overactive Bladder (OAB)\nActive Ingredient: Mirabegron 50mg\nDosage Form: Extended-Release Tablet (ER)\nMechanism of Action: Stimulates beta-3 adrenergic receptors in the bladder, relaxing detrusor smooth muscle, and increasing bladder capacity.\nAdministration: Take orally, usually once daily with or without food.\nEffectiveness: Improves OAB symptoms, reducing urinary frequency and urgency.\nSide Effects: May include headache, hypertension, urinary tract infection, and constipation.\nContraindications: Hypersensitivity to mirabegron, severe uncontrolled hypertension, severe hepatic impairment.\nPrecautions: Monitor blood pressure during treatment, caution in patients with severe renal impairment.\nInteractions: May interact with CYP3A4 inhibitors/inducers, antimuscarinic agents, and digoxin.\nPregnancy/Breastfeeding: Use during pregnancy only if benefits outweigh risks, not recommended during breastfeeding.\nStorage: Store at room temperature away from moisture and heat.\nMirabegron ER 50 provides effective relief for OAB symptoms with a convenient once-daily dosing regimen. However, it's important to follow your healthcare provider's instructions and report any adverse effects promptly. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/miragron-er-50-133492\n\n\n\n\n\n\n", "price": 329.0, "discountamount": 99.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "heat", "drugs", "risks", "ORDER", "Email", "Action", "urgency", "Storage", "digoxin", "WhatsApp", "moisture", "headache", "benefits", "agonists", "patients", "pregnancy", "treatment", "Mechanism", "medication", "Drug Class", "Precautions", "MIRAGRON ER", "information", "instructions", "incontinence", "sterispharma", "constipation", "sterisonline", "Side Effects", "OAB symptoms", "Mirabegron ER", "OAB) symptoms", "Breastfeeding", "Effectiveness", "blood pressure", "Administration", "bladder muscles", "convenient once", "adverse effects", "room temperature", "effective relief", "Hypersensitivity", "bladder capacity", "Contraindications", "Active Ingredient", "urinary frequency", "frequent urination", "overactive bladder", "healthcare provider", "daily dosing regimen", "antimuscarinic agents", "detrusor smooth muscle", "severe renal impairment", "Extended-Release Tablet", "urinary tract infection", "severe hepatic impairment", "CYP3A4 inhibitors/inducers", "beta-3 adrenergic receptors", "Mirabegron 50mg Dosage Form", "severe uncontrolled hypertension", "Beta-3 Adrenergic Agonist Indications" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1666, "imageuri": "https://productimages.withfloats.com/actual/6666d387897f51544741f356.png", "tileimageuri": "https://productimages.withfloats.com/tile/6666d387897f51544741f356.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-10T10:20:52.551Z", "updatedon": "2026-03-16T07:29:47.655Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//miragron-er-50/1666", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MIRAGRON ER 50", "category": "UROLOGYRANGE", "tags": [ "MIRAGRON ER 50 mg", "Mirabegron 50mg", "", "mirabegron 50 mg uses", "", "mirabegron side effects", "", "mirabegron 50 mg price", "", "mirabegron dose", "mirabegron 50 mg and solifenacin" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "663474633661c211fc3f0fd0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SILODOSIA M 50 KIT ", "description": "SILODOSIA M 50 KIT \nCombipack of Mirabegron 50 mg & Silodosin 8 mg\nSiloDosia M 50 Kit is a combination medication pack containing Mirabegron 50 mg and Silodosin 8 mg. Mirabegron is a beta-3 adrenergic receptor agonist used to treat overactive bladder (OAB) symptoms such as frequent urination, urgency, and incontinence. Silodosin is an alpha-1 adrenergic receptor antagonist that helps relax the muscles in the prostate and bladder neck, improving urinary flow in men with benign prostatic hyperplasia (BPH).\n\nThis kit is prescribed to address both OAB symptoms and BPH-related issues in men. Mirabegron works by relaxing the bladder muscle, reducing the frequency of urination and the urgency to urinate. Silodosin acts on the prostate gland and bladder neck muscles, relieving symptoms like difficulty urinating, weak stream, and incomplete emptying of the bladder.\n\nConsult your healthcare provider for proper usage instructions and dosage adjustments based on your medical condition and response to treatment.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n", "price": 570.0, "discountamount": 171.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "urgency", "response", "treatment", "frequency", "Combipack", "difficulty", "weak stream", "incontinence", "OAB symptoms", "urinary flow", "bladder muscle", "Silodosin 8 mg", "prostate gland", "Mirabegron 50 mg", "medical condition", "BPH-related issues", "SILODOSIA M 50 KIT", "dosage adjustments", "frequent urination", "incomplete emptying", "healthcare provider", "bladder neck muscles", "proper usage instructions", "combination medication pack", "benign prostatic hyperplasia", "overactive bladder (OAB) symptoms", "beta-3 adrenergic receptor agonist", "alpha-1 adrenergic receptor antagonist" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1017, "imageuri": "https://productimages.withfloats.com/actual/6634747b151d17d538e1fde6.png", "tileimageuri": "https://productimages.withfloats.com/tile/6634747b151d17d538e1fde6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-03T05:21:39.798Z", "updatedon": "2026-03-17T06:27:22.539Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//silodosia-m-50-kit-/1017", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Combipack of Mirabegron 50 mg & Silodosin 8 mg", "category": "UROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66337ae03661c211fc3f0cf3", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "OXYBUTYRIN 5 ", "description": "OXYBUTYRIN 5 \nOxybutynin Chloride ( 5mg)\nOxybutynin Chloride 5mg, marketed under the brand name OXYBUTYRIN 5, is a medication primarily used for the treatment of overactive bladder. It works by relaxing bladder muscles, effectively reducing urgency, frequency, and episodes of urinary incontinence. This tablet form is designed for oral administration and should be taken as prescribed by a healthcare provider.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n", "price": 121.0, "discountamount": 37.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "urgency", "episodes", "treatment", "frequency", "brand name", "OXYBUTYRIN", "medication", "tablet form", "bladder muscles", "overactive bladder", "oral administration", "healthcare provider", "urinary incontinence", "Oxybutynin Chloride 5mg" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1006, "imageuri": "https://productimages.withfloats.com/actual/66337ae42a7a7008cb63187a.png", "tileimageuri": "https://productimages.withfloats.com/tile/66337ae42a7a7008cb63187a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-02T11:37:04.724Z", "updatedon": "2026-03-17T06:39:15.834Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//oxybutyrin-5-/1006", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Oxybutynin Chloride ( 5mg)", "category": "UROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "663369b44706700b283a0999", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MIRAGRON ER 25", "description": "MIRAGRON ER 25\nMirabegron (25mg)\nMiragron ER 25 is a medication containing 25mg of Mirabegron, specifically designed for the treatment of overactive bladder (OAB). By relaxing the bladder muscles, Mirabegron ER 25 effectively reduces urinary urgency, frequency, and instances of incontinence. This extended-release formulation ensures a steady control of symptoms throughout the day, improving patient comfort and quality of life. Suitable for adults, it is taken once daily.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n", "price": 229.0, "discountamount": 69.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "OAB", "25mg", "life", "adults", "quality", "symptoms", "treatment", "frequency", "instances", "medication", "MIRAGRON ER", "incontinence", "Mirabegron ER", "steady control", "patient comfort", "urinary urgency", "bladder muscles", "overactive bladder", "extended-release formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1001, "imageuri": "https://productimages.withfloats.com/actual/663369b7c76b7398ff857fed.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/663369b7c76b7398ff857fed.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-02T10:23:48.806Z", "updatedon": "2026-03-16T07:28:16.67Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//miragron-er-25/1001", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Mirabegron (25mg)", "category": "UROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a8c3838c90065ecdc86c757", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 4mg", "description": "SAMIGLUTIDE 4 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation contains 4 mg of semaglutide in 3 mL of solution, corresponding to approximately 1.34 mg/mL.\n\nSemaglutide is a GLP-1 receptor agonist that acts on physiological pathways involved in blood-glucose control, appetite, and gastrointestinal function. Its use should be based on the approved indication for the specific product and the advice of a qualified healthcare professional.\n\nProduct Overview\nProduct: SAMIGLUTIDE 4 MG\nActive substance: Semaglutide\nStrength: 4 mg/3 mL\nApproximate concentration: 1.34 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute: Subcutaneous administration, according to the applicable product instructions\n\nThe 4 mg/3 mL concentration is also associated with certain approved semaglutide products. However, this does not mean that their dosing schedules, indications, or administration instructions automatically apply to SAMIGLUTIDE 4 MG. The product-specific labeling should always be followed.\n\nWhat Is Semaglutide?\n\nSemaglutide is a medication belonging to the GLP-1 receptor agonist class. It acts similarly to the naturally occurring hormone glucagon-like peptide-1 (GLP-1).\n\nGLP-1 is involved in several processes related to metabolism. Its activity can influence insulin secretion, glucagon regulation, stomach emptying, and appetite. Depending on the particular semaglutide product and its regulatory authorization, semaglutide may be prescribed for conditions such as type 2 diabetes or chronic weight management in appropriately selected patients.\n\nBecause different semaglutide products can have different approved uses and formulations, treatment decisions should be based on the specific medicine being prescribed.\n\nSAMIGLUTIDE 4 MG Pre-Filled Pen\n\nSAMIGLUTIDE 4 MG is supplied in a pre-filled pen intended to provide a convenient format for subcutaneous administration.\n\nPre-filled devices can eliminate the need to draw medication from a conventional vial. Nevertheless, patients should be properly trained before using an injectable pen and should follow the instructions supplied with the specific product.\n\nThe pen should only be used according to its approved instructions, including the prescribed dose and administration schedule.\n\nStrength and Formulation\n\nEach stated 3 mL presentation contains 4 mg of semaglutide, giving a concentration of approximately 1.34 mg/mL.\n\nThe concentration of a medicine should not be confused with the amount delivered in every injection. The quantity administered depends on the design and dose settings of the particular pen.\n\nFor this reason, patients should not calculate or select their own dose based solely on the concentration printed on the package. The prescribed dose should come from the product's authorized instructions and the treating healthcare professional.\n\nHow Semaglutide Acts\n\nSemaglutide activates GLP-1 receptors, which are involved in the regulation of blood glucose and appetite.\n\nAmong its physiological effects, GLP-1 receptor activation can:\n\nSupport glucose-dependent insulin secretion.\nReduce inappropriate glucagon secretion when blood glucose is elevated.\nAffect gastrointestinal activity, including gastric emptying.\nInfluence appetite and food intake.\n\nThe overall response to treatment can vary between individuals and depends on factors such as the medical indication, prescribed dose, treatment duration, and other medicines being used.\n\nPotential Therapeutic Benefits\n\nWhen prescribed for an appropriate, authorized indication, semaglutide may form part of a broader treatment program.\n\nFor eligible individuals with type 2 diabetes, certain approved semaglutide medicines are used to improve glycemic control. Other approved semaglutide formulations have indications involving chronic weight management for qualifying patients.\n\nMedication should be considered alongside the broader treatment strategy recommended by a healthcare professional, which may include nutritional management, physical activity, glucose monitoring, and other appropriate interventions.\n\nPossible Side Effects\n\nLike other prescription medicines, semaglutide can cause unwanted effects.\n\nFrequently reported gastrointestinal reactions associated with semaglutide products include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort or pain\n\nNot every patient experiences these effects, and their severity can vary.\n\nSemaglutide products also have important safety considerations. Depending on the specific approved product, labeling includes warnings concerning conditions such as pancreatitis, gallbladder-related problems, severe gastrointestinal reactions, kidney problems associated with dehydration, and serious hypersensitivity reactions.\n\nPatients should provide their healthcare professional with a complete medical history before treatment begins.\n\nImportant Contraindications and Warnings\n\nCertain semaglutide products carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Serious hypersensitivity to semaglutide or an applicable component is also an important contraindication.\n\nThe exact warnings and contraindications applicable to SAMIGLUTIDE 4 MG should be confirmed against its current authorized product information in the relevant country.\n\nPatients should seek professional medical advice if they develop concerning symptoms during treatment.\n\nCorrect Administration\n\nSAMIGLUTIDE 4 MG should be administered only according to the prescription and instructions applicable to the product.\n\nBefore using a pre-filled pen, patients should receive appropriate instruction regarding:\n\nDose selection\nInjection technique\nInjection sites\nPen operation\nStorage\nDisposal of used needles or injection equipment\n\nThe dose or frequency should never be changed independently.\n\nA pre-filled injection pen should not be shared with another person, even if a new needle is attached. Sharing injectable medication devices can create a risk of transmitting infections and is contrary to appropriate safe-use practices.\n\nStorage\n\nStorage requirements should be determined from the official SAMIGLUTIDE 4 MG packaging and product information supplied with the medicine.\n\nPatients should not rely on storage instructions from a different semaglutide brand because formulations, devices, and stability requirements can differ between products.\n\nUse by Healthcare Professionals\n\nHealthcare professionals should assess whether SAMIGLUTIDE 4 MG is appropriate for an individual patient by considering the relevant diagnosis, treatment objectives, medical history, contraindications, concurrent medicines, and applicable regulatory requirements.\n\nParticular attention should be given to the distinction between different semaglutide products. Although they contain the same active ingredient, products may differ in:\n\nApproved indications\nConcentration\nPen design\nDose increments\nAdministration schedules\nStorage conditions\nRegulatory labeling\n\nThe product-specific prescribing information should therefore be consulted before treatment is initiated or adjusted.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can provide a practical method of administering an injectable medicine. Compared with a conventional vial-and-syringe presentation, the device may reduce some preparation steps and can be convenient for patients who have been appropriately trained.\n\nConvenience, however, should not take precedence over product authenticity, regulatory approval, correct dosing, proper storage, and professional medical supervision.\n\nSAMIGLUTIDE 4 MG: Key Points\n\nSAMIGLUTIDE 4 MG is described as a semaglutide injection containing 4 mg in 3 mL, supplied in a pre-filled pen.\n\nThe most important considerations are:\n\nSemaglutide is a GLP-1 receptor agonist.\nThe stated formulation is 4 mg/3 mL (approximately 1.34 mg/mL).\nAdministration is by the subcutaneous route when prescribed for that route.\nThe appropriate dose and frequency must come from the product-specific instructions and prescription.\nDosing information from another semaglutide brand should not automatically be applied.\nPatients should be informed about possible adverse reactions and relevant contraindications.\nThe pen must not be shared between patients.\nStorage and handling should follow the official product information.\nTreatment should be supervised by an appropriately qualified healthcare professional.\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 4 MG?\n\nSAMIGLUTIDE 4 MG is a semaglutide-containing injectable formulation described as 4 mg/3 mL, supplied in a pre-filled pen. Its approved use depends on the regulatory authorization applicable to the product and market.\n\nWhat does 4 mg/3 mL mean?\n\nIt indicates that the stated 3 mL presentation contains a total of 4 mg of semaglutide, equivalent to approximately 1.34 mg of semaglutide per mL.\n\nThis concentration alone should not be used to determine an individual's injection dose.\n\nIs SAMIGLUTIDE 4 MG a prescription medicine?\n\nSemaglutide medicines are prescription products in many jurisdictions. SAMIGLUTIDE 4 MG should be used only in accordance with applicable regulations, authorized product information, and professional medical advice.\n\nHow is SAMIGLUTIDE 4 MG administered?\n\nThe product is described as a subcutaneous injection. However, the exact dose, injection frequency, and pen operation should be determined from the SAMIGLUTIDE 4 MG product information and the patient's prescription.\n\nCan SAMIGLUTIDE 4 MG be taken together with another semaglutide medicine?\n\nPatients should not combine semaglutide-containing medicines or switch between them without medical supervision. Some approved semaglutide labels specifically advise against combining their product with another semaglutide-containing medicine or another GLP-1 receptor agonist.\n\nCan the dose be changed without consulting a doctor?\n\nNo. Patients should not increase, decrease, or otherwise modify the prescribed dose or injection schedule without guidance from their healthcare professional.\n\nConclusion\n\nSAMIGLUTIDE 4 MG – Semaglutide Injection 4 mg/3 mL (approximately 1.34 mg/mL) Pre-Filled Pen is a semaglutide-based injectable formulation designed for subcutaneous use according to its applicable product instructions.\n\nBecause semaglutide products can vary substantially in their approved indications, concentrations, devices, and dosing regimens, information from another semaglutide product should not be assumed to apply to SAMIGLUTIDE 4 MG.\n\nFor appropriate and safe use, patients and healthcare professionals should rely on the current official product information, local regulatory authorization, and individualized medical advice. Any questions concerning suitability, dosing, interactions, contraindications, or adverse effects should be discussed with a qualified healthcare professional.", "price": 6600.0, "discountamount": 1980.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2497, "imageuri": "https://productimages.withfloats.com/actual/6a8c383c0e00e8a5dab0c9d5.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c383c0e00e8a5dab0c9d5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:25:28.659Z", "updatedon": "2026-08-24T12:25:28.659Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-4mg/2497", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 4 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a8c35e76d1f6b0cbc0e2e40", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 2 mg", "description": "SAMIGLUTIDE 2 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation is Semaglutide Injection 2 mg/3 mL (0.68 mg/mL). Semaglutide belongs to the GLP-1 receptor agonist class and is a prescription medicine that should be used only under the supervision of an appropriately qualified healthcare professional.\n\nSAMIGLUTIDE 2 MG Composition\n\nEach 3 mL pre-filled pen is stated to contain:\n\nActive substance: Semaglutide\nStrength: 2 mg/3 mL\nConcentration: 0.68 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute of administration: Subcutaneous, according to the applicable product instructions\n\nSemaglutide acts on GLP-1 receptors, which are involved in blood-glucose regulation and appetite control. The approved uses, dosage regimen and strength available can differ according to the specific product and the regulations of the country in which it is supplied.\n\nWhat Is Semaglutide?\n\nSemaglutide is a synthetic peptide that mimics the activity of the naturally occurring hormone glucagon-like peptide-1 (GLP-1). By activating GLP-1 receptors, it can influence several physiological processes, including glucose-dependent insulin release, glucagon secretion, gastric emptying and appetite.\n\nThe appropriate dose and treatment schedule depend on the individual patient and the particular semaglutide formulation. Patients should follow their healthcare professional's instructions and should not alter the prescribed regimen independently.\n\nSAMIGLUTIDE 2 MG Pre-Filled Pen\n\nSAMIGLUTIDE 2 MG is presented as a pre-filled injection pen intended to provide a convenient method of administration when the medicine has been prescribed.\n\nSince semaglutide products can differ in concentration, pen design and dose-delivery mechanism, users should carefully verify the product label and prescribed dose before each administration. Particular care is important with injectable semaglutide products because differences in concentration or measurement methods can result in medication errors.\n\nPotential Medical Uses\n\nSemaglutide may be used for particular medical conditions depending on the formulation, regulatory approval and prescribing information applicable to the product.\n\nCertain approved semaglutide medicines are indicated for the treatment of type 2 diabetes, while other formulations have approved indications involving chronic weight management in eligible patients. Some products may also have additional approved indications for reducing specific cardiovascular risks.\n\nThe fact that semaglutide can be used for weight management does not mean that every semaglutide product is approved for that purpose. The authorization and labeling of SAMIGLUTIDE should therefore be confirmed from current official product documentation.\n\nHow Semaglutide Works\n\nSemaglutide activates GLP-1 receptors in the body. Its effects can contribute to improved regulation of blood glucose and reduced appetite and food intake. Depending on the approved indication, it may be prescribed together with dietary, physical-activity or other appropriate medical measures.\n\nIndividual responses can vary. Medical follow-up helps healthcare professionals evaluate treatment response, tolerability and whether treatment should be continued or modified.\n\nDosage and Administration\n\nSAMIGLUTIDE 2 MG should be administered only in accordance with the prescription and the manufacturer's current instructions.\n\nThe amount of semaglutide contained in a pen should not automatically be interpreted as the amount to inject at one time. Different products may use different concentrations, dose settings and administration schedules.\n\nFor approved semaglutide products, treatment may involve gradual dose increases for certain indications. Patients should never increase the dose, inject more frequently or repeat a missed dose without receiving appropriate medical instructions.\n\nPossible Side Effects\n\nSemaglutide can cause adverse effects, particularly gastrointestinal symptoms. Frequently reported effects may include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nAbdominal pain\n\nMore serious reactions are also possible. Product information for semaglutide medicines includes warnings relating to conditions such as pancreatitis and gallbladder disorders, among other potential risks.\n\nPersistent, severe or unusual symptoms should be discussed promptly with a healthcare professional. Patients should review the complete prescribing information supplied with their particular product.\n\nImportant Safety Information\n\nSemaglutide is not appropriate for everyone. For example, certain approved semaglutide products in the United States carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC), people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and individuals with a serious hypersensitivity to semaglutide or an ingredient in the relevant product.\n\nThese precautions should not automatically be assumed to apply identically to every semaglutide product worldwide. The manufacturer's labeling and the regulatory requirements of the relevant country should always be consulted.\n\nPatients should inform their healthcare professional about their medical history and other medicines before starting treatment.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can make injectable treatment more convenient by providing the medication in a ready-to-use delivery device. When used according to the manufacturer's instructions, the pen may simplify administration and help patients maintain their prescribed treatment routine.\n\nPatients should nevertheless receive appropriate guidance regarding injection technique, storage, handling and disposal. The convenience of a pen does not eliminate the need for medical supervision.\n\nStorage and Handling\n\nSAMIGLUTIDE 2 MG should be stored exactly as stated on its packaging and official product information. Appropriate storage conditions are important for maintaining the quality and stability of the medicine.\n\nBefore use, check the expiry date and inspect the packaging and medicine according to the manufacturer's instructions. Do not use the product if the packaging is damaged or if the solution has an appearance that does not meet the stated product requirements.\n\nConclusion\n\nSAMIGLUTIDE 2 MG – Semaglutide Injection 2 mg/3 mL (0.68 mg/mL) is a semaglutide-based injectable formulation supplied in a pre-filled pen. Semaglutide is a GLP-1 receptor agonist with established medical applications for appropriately selected patients, depending on the specific product and its regulatory authorization.\n\nSafe use requires adherence to the prescribed dose and administration schedule. Patients should not independently change their dose or frequency and should seek professional advice if they experience concerning adverse effects.\n\nBecause formulations, indications, strengths and regulatory requirements can vary between products and countries, the current official package insert and applicable regulatory labeling should be used to verify product-specific information.\n\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 2 MG?\n\nSAMIGLUTIDE 2 MG is described as a semaglutide injection containing 2 mg of semaglutide in 3 mL, with a stated concentration of 0.68 mg/mL, supplied in a pre-filled pen.\n\nIs SAMIGLUTIDE 2 MG used for weight management?\n\nSemaglutide is included in certain approved medicines used for chronic weight management in eligible patients. However, the indication for a specific SAMIGLUTIDE product must be confirmed from its current regulatory approval and official labeling.\n\nHow frequently is SAMIGLUTIDE 2 MG injected?\n\nThe correct frequency depends on the specific product and the prescription issued by the healthcare professional. Patients should not determine the injection schedule based solely on the amount printed on the pen.\n\nCan SAMIGLUTIDE 2 MG be taken without medical supervision?\n\nNo. Semaglutide is a prescription medicine in many jurisdictions and should be obtained and used through legitimate, appropriately regulated healthcare channels.\n\nIs SAMIGLUTIDE the same as other branded semaglutide medicines?\n\nNot necessarily. Products containing semaglutide can differ in manufacturer, formulation, concentration, delivery device, regulatory approval and approved indications. A specific product should not be described as identical to an approved branded medicine unless that claim can be verified through reliable regulatory and product documentation.\n\nWhat should patients check before using the pen?\n\nPatients should verify the medicine name, strength, prescribed dose, expiry date, storage conditions and administration instructions. If there is any uncertainty about the dose or operation of the pen, they should consult their pharmacist, prescriber or another qualified healthcare professional rather than guessing.", "price": 5600.0, "discountamount": 1680.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2496, "imageuri": "https://productimages.withfloats.com/actual/6a8c35eaca4d2575d78e3716.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c35eaca4d2575d78e3716.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:15:35.873Z", "updatedon": "2026-08-24T12:15:35.873Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-2-mg/2496", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 2 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a5df739c15b0b6844e869c2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Olanzapine Mouth Dissolving Tablets 20 mg", "description": "OLANZPRIME 20 is a 20 mg Olanzapine mouth-dissolving tablet used to manage schizophrenia and bipolar disorder, typically for patients whose psychiatrist has determined a higher dose is appropriate than the standard 15 mg strength. It calms overactive dopamine and serotonin signaling in the brain, easing hallucinations, delusions, and mood instability. The tablet dissolves on the tongue in seconds, so no water is needed — a practical advantage for elderly patients or anyone who struggles with swallowing. Because higher-dose Olanzapine carries a somewhat greater chance of metabolic side effects like weight gain, regular monitoring is often advised. Prescription only – consult your doctor.\n\nMeta Title Options (50–60 characters)\nOLANZPRIME 20 Price – Olanzapine 20mg MD Tablet (Recommended)\nOLANZPRIME 20mg – Mouth Dissolving Antipsychotic\nOLANZPRIME 20 Price – Higher-Dose Olanzapine MD\nOlanzapine 20mg MD Tablet – OLANZPRIME Price Online\nOLANZPRIME 20 – Schizophrenia & Bipolar MD Tablet\n\nRationale: Option 1 leads with the “Price” anchor required for this Schedule H product and specifies the 20 mg strength clearly, helping differentiate it in search from the 15 mg SKU while staying within character limits.\n\nMeta Description (140–160 characters)\n\nOLANZPRIME 20 delivers higher-dose Olanzapine in an MD tablet for schizophrenia & bipolar care. Check price online. Prescription only – doctor advised.\n\nFull CMS Article\nOLANZPRIME 20: Higher-Strength Olanzapine Mouth Dissolving Tablet for Psychiatric Care\nTL;DR / AI Mode Summary\n\nOLANZPRIME 20 provides Olanzapine at a 20 mg strength in a fast-dissolving tablet form, prescribed for schizophrenia, bipolar disorder, and related conditions where a psychiatrist determines a higher dose is clinically needed. Like other Olanzapine formulations, it works on dopamine and serotonin pathways to steady mood and reduce psychotic symptoms. The dissolving format skips the need for water, which helps with adherence in patients who find tablet-swallowing difficult. Given the higher strength, monitoring for metabolic changes — weight, blood sugar, lipids — is a routine part of long-term care.\n\nUnderstanding OLANZPRIME 20\n\nNot every patient responds the same way to a starting dose of Olanzapine. Where symptoms remain inadequately controlled at lower strengths, or where a psychiatrist's clinical judgment calls for a higher therapeutic level, OLANZPRIME 20 offers the 20 mg strength in the same convenient mouth-dissolving format — sparing patients the need to switch to swallowing multiple lower-strength tablets or handle water-based dosing.\n\nComposition at a Glance\nAttribute\tDetail\nBrand Name\tOLANZPRIME 20\nActive Ingredient\tOlanzapine\nStrength\t20 mg\nForm\tMouth Dissolving Tablet (MD)\nRoute\tOral\nTherapeutic Class\tAtypical Antipsychotic\nSchedule Status\tSchedule H – Prescription Only\nConditions It's Prescribed For\nSchizophrenia\nBipolar I Disorder, including acute manic episodes\nLong-term maintenance care for bipolar disorder\nPsychotic disorders more broadly\nMood disorders, at a psychiatrist's discretion\nAgitation linked to certain psychiatric presentations\n\nThe aim across these conditions is the same: dial down hallucinations, delusions, and disorganized thought enough that patients can re-engage with daily routines and relationships.\n\nMechanism of Action\n\nSymptoms like hallucinations, mood swings, and confused thinking are strongly linked to overactive dopamine (D2) receptor signaling, along with disrupted serotonin (5-HT2A) activity in the brain.\n\nAt the 20 mg strength, Olanzapine:\n\nBlocks excess dopamine receptor activity more fully than lower doses may achieve\nModulates serotonin signaling alongside dopamine\nEases hallucinations, delusions, and anxiety tied to psychotic symptoms\nSupports steadier mood and reduced aggression\nHelps restore clearer, more organized thinking\n\nThe mouth-dissolving format means the tablet breaks down on the tongue within moments, which is particularly useful for elderly patients or anyone managing swallowing difficulty alongside their psychiatric condition.\n\nDirections for Use\nTake OLANZPRIME 20 only in the dose and frequency your psychiatrist prescribes — do not self-adjust to a higher or lower strength.\nPlace the tablet on the tongue and let it dissolve fully without chewing.\nSwallow once dissolved; water isn't usually necessary.\nTake it at a consistent time each day.\nComplete the full course your doctor recommends, even if you start feeling better.\nNever stop abruptly — sudden discontinuation can trigger symptom relapse or withdrawal-type effects.\nPossible Side Effects\n\nCommon, generally manageable effects include:\n\nDrowsiness or sleepiness\nIncreased appetite\nWeight gain\nDry mouth\nConstipation\nDizziness\nFatigue\nTremors\nRestlessness\n\nLess common but more serious effects can include severe allergic reactions, uncontrolled muscle movements, very high fever, or signs of elevated blood sugar. Because the 20 mg strength is a higher dose, these metabolic and neurological effects warrant closer attention.\n\nPlaceholder: incidence rates and dose-comparison trial data pending qualified clinical reviewer sign-off before publication.\n\nSeek emergency care immediately if any of these serious symptoms appear.\n\nWho Should Be Cautious\n\nShare your full medical history with your doctor before starting, especially if you have:\n\nDiabetes or a family history of diabetes\nLiver or kidney disease\nHeart disease\nHigh cholesterol or triglycerides\nEpilepsy or seizure disorders\nGlaucoma\nParkinson's disease\nDementia, particularly in older patients\nA prior stroke\nPrecautions & Lifestyle Considerations\nAvoid alcohol, since it can compound drowsiness.\nBe cautious with driving or operating machinery until you know how the medicine affects you.\nBecause Olanzapine — especially at higher strengths — can contribute to weight gain, a balanced diet and regular activity are worth building into your routine.\nLong-term treatment typically includes periodic checks of blood sugar, lipid levels, and body weight.\nIn pregnancy or while breastfeeding, use only if your doctor has weighed the benefits against potential risks.\nStorage Instructions\nStore below 25°C, protected from moisture, heat, and direct sunlight.\nKeep tablets in the original blister pack until the moment of use.\nKeep out of reach of children.\nDo not use past the expiry date printed on the pack.\nComparing Olanzapine Strengths\nStrength\tTypical Scenario\tConsiderations\nOLANZPRIME 15 (15 mg)\tStandard starting or maintenance dose\tSuitable for many patients as an initial therapeutic level\nOLANZPRIME 20 (20 mg)\tHigher therapeutic need per psychiatrist's assessment\tMay carry a somewhat greater likelihood of metabolic side effects; monitoring emphasized\n\nNote: The right strength is determined entirely by a psychiatrist's clinical assessment — patients should never switch strengths on their own.\n\nWhy Choose OLANZPRIME 20?\n\nFor patients who need a higher Olanzapine dose but still benefit from a swallow-free administration route, OLANZPRIME 20 combines both. It's manufactured to consistent pharmaceutical quality standards, giving psychiatrists, hospitals, and pharmacies a dependable higher-strength option without sacrificing the ease-of-use that mouth-dissolving tablets are known for.\n\nConclusion\n\nManaging schizophrenia or bipolar disorder sometimes calls for a higher Olanzapine dose than a standard starting regimen provides. OLANZPRIME 20 delivers that strength in a mouth-dissolving format that keeps daily administration simple, even for patients who find conventional tablets difficult to manage. Taken consistently under a psychiatrist's supervision, with regular monitoring for metabolic changes, it supports steadier, more manageable day-to-day functioning. Prescription only – consult your doctor.\n\nFrequently Asked Questions\nWhat is OLANZPRIME 20 used for? It's prescribed for schizophrenia, bipolar disorder, and other psychiatric conditions where a psychiatrist determines this higher strength is appropriate.\nHow is OLANZPRIME 20 different from OLANZPRIME 15? Both contain Olanzapine in the same mouth-dissolving format; OLANZPRIME 20 is a higher 20 mg strength used when a psychiatrist assesses that a greater dose is clinically needed.\nHow should I take it? Place the tablet on your tongue, let it dissolve fully, and swallow naturally — always following your doctor's exact dosing.\nDo I need water to take this tablet? No, it's designed to dissolve on the tongue without water.\nCan OLANZPRIME 20 cause weight gain? Yes, weight gain and increased appetite are known effects, and the risk may be somewhat higher at this strength — regular monitoring and healthy habits can help manage it.\nIs this strength safe for long-term use? Yes, under a psychiatrist's ongoing supervision, with periodic checks of weight, blood sugar, and lipid levels.\nCan I switch from OLANZPRIME 15 to OLANZPRIME 20 on my own? No — any change in strength must be directed by your prescribing psychiatrist.\nWhat happens if I stop taking it suddenly? Stopping abruptly can lead to symptom relapse or withdrawal-type effects; any discontinuation should be gradual and doctor-guided.\nDoes alcohol interact with OLANZPRIME 20? Yes, alcohol can intensify drowsiness and should generally be avoided during treatment.\nIs it safe to drive while taking this medicine? Use caution with driving or operating machinery until you understand how the medicine affects your alertness and coordination.\nWhat health conditions should I disclose before starting? Mention diabetes, liver or kidney disease, heart disease, high cholesterol, epilepsy, glaucoma, Parkinson's disease, dementia, or a history of stroke.\nWhat serious symptoms need immediate medical attention? Severe allergic reactions, uncontrolled muscle movements, very high fever, or signs of very high blood sugar require urgent care.\nCan this be used during pregnancy? Only under medical supervision, after your doctor weighs the potential benefits against risks.\nIs a prescription required to buy OLANZPRIME 20? Yes, it is a Schedule H medicine and can only be dispensed against a valid doctor's prescription.\nHow long until I notice improvement? This varies by individual and condition; your psychiatrist will track progress through scheduled follow-ups.\n\n[Steris Healthcare Footer] Manufactured and marketed by Steris Healthcare Pvt. Ltd. — a WHO-GMP and ISO-certified pharmaceutical manufacturer. For queries, reach us at contact@sterispharma.com or +91 8824175417. This content is for informational purposes only and does not replace professional medical advice. Prescription only – consult your doctor.", "price": 245.0, "discountamount": 73.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2479, "imageuri": "https://productimages.withfloats.com/actual/6a5df73c6c57d63669881829.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a5df73c6c57d63669881829.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-20T10:23:53.814Z", "updatedon": "2026-07-20T10:23:53.814Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//olanzapine-mouth-dissolving-tablets-20-mg/2479", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OLANZPRIME 20", "category": "NEUROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a05af2f5973eae52aa766f8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "gabapentin sustained release tablets 450 mg", "description": "Introduction to Gabapentin Sustained Release Tablets 450 mg\n\nGabapentin Sustained Release Tablets 450 mg are widely prescribed for the management of nerve-related pain and certain neurological conditions. These tablets are formulated with sustained-release technology, which allows the medicine to release gradually in the body over time. This helps maintain a stable therapeutic effect and reduces the need for frequent dosing.\n\nPatients suffering from neuropathic pain, diabetic nerve pain, post-herpetic neuralgia, or other nerve disorders often look for long-lasting and effective relief. Gabapentin Sustained Release Tablets 450 mg are designed to provide extended support throughout the day while improving patient comfort and compliance.\n\nThe sustained-release formulation is especially beneficial for individuals who require continuous symptom management without experiencing sudden fluctuations in medicine levels. Healthcare professionals frequently recommend this dosage because of its balanced effectiveness and convenient administration.\n\nWhat Are Gabapentin Sustained Release Tablets 450 mg?\n\nGabapentin Sustained Release Tablets 450 mg contain gabapentin as the active pharmaceutical ingredient. Gabapentin belongs to a class of medicines known as anticonvulsants or nerve pain modulators. It is commonly used to control abnormal nerve signals in the body.\n\nUnlike immediate-release formulations, sustained-release tablets slowly release the medication over several hours. This controlled release mechanism helps in maintaining prolonged relief from nerve pain and discomfort.\n\nThese tablets are often prescribed for:\n\nNeuropathic pain\nDiabetic neuropathy\nPost-herpetic neuralgia\nFibromyalgia-related nerve discomfort\nCertain seizure disorders\nChronic nerve-related pain conditions\n\nBecause nerve pain can significantly affect daily life, sleep quality, and mobility, many patients prefer sustained-release formulations for their consistent action and reduced dosing frequency.\n\nHow Gabapentin Sustained Release Tablets 450 mg Work\n\nGabapentin works by affecting the transmission of nerve signals in the central nervous system. In nerve pain conditions, damaged nerves may send abnormal pain signals to the brain. Gabapentin helps calm these overactive nerve impulses and reduces the sensation of pain, burning, tingling, or numbness.\n\nThe sustained-release technology ensures that the medicine is gradually absorbed into the bloodstream. This offers several advantages:\n\nLonger-lasting pain relief\nReduced fluctuations in drug levels\nBetter nighttime symptom control\nImproved patient adherence\nLower frequency of dosing\n\nPatients with chronic neuropathic conditions often benefit from the steady therapeutic action provided by Gabapentin Sustained Release Tablets 450 mg.\n\nUses of Gabapentin Sustained Release Tablets 450 mg\n\nGabapentin Sustained Release Tablets 450 mg are commonly used in the treatment and management of multiple conditions related to nerve dysfunction.\n\n1. Neuropathic Pain\n\nNeuropathic pain develops due to nerve damage or malfunction. Patients may experience sharp pain, burning sensations, tingling, or electric shock-like discomfort. Gabapentin helps reduce these symptoms effectively.\n\n2. Diabetic Neuropathy\n\nPeople with diabetes may develop nerve damage over time, especially in the legs and feet. Gabapentin Sustained Release Tablets 450 mg help control pain, numbness, and discomfort associated with diabetic neuropathy.\n\n3. Post-Herpetic Neuralgia\n\nAfter shingles infection, some patients continue to experience persistent nerve pain. Gabapentin is commonly prescribed to manage this condition and improve quality of life.\n\n4. Partial Seizures\n\nGabapentin may also be used as an adjunct therapy in certain seizure disorders under medical supervision.\n\n5. Fibromyalgia and Chronic Pain Disorders\n\nSome healthcare professionals recommend gabapentin for chronic pain syndromes involving nerve sensitivity and persistent discomfort.\n\nBenefits of Gabapentin Sustained Release Tablets 450 mg\nLong-Lasting Relief\n\nThe sustained-release formulation provides extended symptom management throughout the day and night.\n\nImproved Patient Convenience\n\nReduced dosing frequency makes it easier for patients to follow their treatment schedule consistently.\n\nStable Therapeutic Effect\n\nThe gradual release mechanism helps maintain balanced medicine levels in the body.\n\nBetter Sleep Quality\n\nMany patients with nerve pain struggle to sleep because of discomfort. Gabapentin may help reduce nighttime pain and improve rest.\n\nEnhanced Daily Functioning\n\nBy controlling chronic nerve pain, patients can experience better mobility, comfort, and overall quality of life.\n\nReduced Sudden Drug Peaks\n\nSustained-release tablets help avoid abrupt rises and falls in medicine concentration, contributing to smoother symptom control.\n\nWho May Need Gabapentin Sustained Release Tablets 450 mg?\n\nGabapentin Sustained Release Tablets 450 mg may be recommended for:\n\nAdults with chronic nerve pain\nPatients suffering from diabetic neuropathy\nIndividuals with post-shingles nerve pain\nPatients requiring prolonged pain control\nIndividuals experiencing tingling, numbness, or burning sensations\nPatients needing supportive seizure management\n\nA healthcare professional will determine the appropriate dosage and duration depending on the patient’s condition and response to therapy.\n\nHow to Take Gabapentin Sustained Release Tablets 450 mg\n\nPatients should always follow the dosage instructions provided by their healthcare provider.\n\nGeneral administration guidelines include:\n\nSwallow the tablet whole with water\nDo not crush, chew, or break the tablet\nTake the medicine at the same time daily\nCan be taken with or without food, depending on medical advice\nAvoid missing doses for consistent symptom control\n\nThe sustained-release mechanism works properly only when the tablet is taken intact.\n\nPossible Side Effects of Gabapentin Sustained Release Tablets 450 mg\n\nLike all medicines, Gabapentin Sustained Release Tablets 450 mg may cause some side effects in certain individuals. Most side effects are mild to moderate and may decrease as the body adjusts to the medication.\n\nCommon side effects may include:\n\nDizziness\nDrowsiness\nFatigue\nSleepiness\nCoordination problems\nBlurred vision\nSwelling in hands or feet\nDry mouth\n\nPatients should seek medical attention if they experience severe allergic reactions, breathing difficulties, or unusual behavioral changes.\n\nPrecautions and Safety Information\n\nBefore taking Gabapentin Sustained Release Tablets 450 mg, patients should inform their healthcare provider about any existing medical conditions or ongoing treatments.\n\nImportant precautions include:\n\nUse cautiously in kidney disorders\nAvoid alcohol consumption during treatment\nDo not suddenly stop the medication without medical advice\nInform the doctor about pregnancy or breastfeeding\nUse caution while driving or operating machinery if dizziness occurs\n\nFollowing medical guidance helps ensure safe and effective treatment outcomes.\n\nWhy Choose Gabapentin Sustained Release Tablets 450 mg?\n\nPatients and healthcare providers often prefer Gabapentin Sustained Release Tablets 450 mg because of their reliable symptom management and patient-friendly formulation.\n\nKey reasons include:\n\nExtended-release technology\nConsistent pain management\nConvenient once or twice daily dosing\nSuitable for chronic conditions\nImproved treatment adherence\nEffective management of neuropathic symptoms\n\nThe formulation is particularly useful for patients seeking long-duration relief from persistent nerve pain.\n\nStorage Instructions\n\nProper storage helps maintain the quality and effectiveness of the medicine.\n\nStore in a cool and dry place\nKeep away from direct sunlight\nProtect from moisture\nKeep out of reach of children\nDo not use expired medication\n\nAlways check packaging instructions for specific storage recommendations.\n\nConclusion\n\nGabapentin Sustained Release Tablets 450 mg are an effective and widely trusted option for managing neuropathic pain and related neurological conditions. With sustained-release technology, these tablets provide prolonged relief, stable symptom control, and improved patient convenience.\n\nWhether used for diabetic neuropathy, post-herpetic neuralgia, chronic nerve pain, or supportive seizure therapy, Gabapentin Sustained Release Tablets 450 mg helps patients achieve better comfort and daily functioning. Their long-lasting action, convenient dosing schedule, and reliable therapeutic effect make them a preferred choice for many healthcare professionals and patients alike.", "price": 375.0, "discountamount": 112.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2421, "imageuri": "https://productimages.withfloats.com/actual/6a05af338d715b31cefe444d.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6a05af338d715b31cefe444d.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-05-14T11:17:03.427Z", "updatedon": "2026-05-14T11:17:03.427Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//gabapentin-sustained-release-tablets-450-mg/2421", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Stargab SR 450", "category": "NEUROLOGY RANGE", "tags": [ "gabapentin sustained release tablets 450 mg", "Gabapentin Sustained Release Tablets 450 mg", "Gabapentin 450 mg Neuropathic Pain Treatment Tablets", "Nerve Pain Relief Medicine Gabapentin 450 mg", "Gabapentin SR 450 mg Prescription Medicine", "Sustained Release Gabapentin Tablets 450 mg", "Gabapentin 450 mg Product Image", "Gabapentin SR 450 mg Pharmaceutical Medicine", "Gabapentin 450 mg Extended Release Tablets", "Oral Gabapentin Sustained Release Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }